Active-ingredient Dossier
"tenofovir Alafenamide"]
Active-ingredient Dossier for "tenofovir Alafenamide"] (nucleotide reverse transcriptase inhibitor). Australian brands, products, PBS listings, PBAC…
- Brand: ODOFORIL
- Therapeutic area: Infectious Disease
What is
Tenofovir Alafenamide Tenofovir Alafenamide is a nucleotide reverse transcriptase inhibitor.
Australian brands containing
Tenofovir Alafenamide — SYMTUZA — DESCOVY — ODEFSEY
Therapeutic areas
Tenofovir Alafenamide is registered in Infectious Disease, with 3 brands containing the ingredient.
Sponsor landscape
Tenofovir Alafenamide is marketed by two sponsors: Gilead Sciences and Janssen-Cilag.
PBS and regulatory activity
No brands containing Tenofovir Alafenamide are currently listed on the PBS. The latest PBAC outcome was recorded on 1 November 2019, and the latest AusPAR was issued on 28 June 2016.